Clarksville, TN Online: News, Opinion, Arts & Entertainment.


Topic: Division of Cardiovascular and Renal Products

FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation

 

Washington, D.C.U.S. Food and Drug Administration - FDAThe U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Atrial fibrillation, one of the most common types of abnormal heart rhythm, is an abnormal, irregular, and rapid beating of the heart in which the heart’s two upper chambers (atria) do not contract properly, allowing blood clots to form in them. These clots can break off and travel to the brain or other parts of the body.  «Read the rest of this article»

Sections: News | No Comments
 



Personal Controls

Archives

    July 2016
    S M T W T F S
    « Jun    
     12
    3456789
    10111213141516
    17181920212223
    24252627282930
    31